Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Croft

Showing results (221-230 of 225) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 225 results.
Gut|March 23, 2021
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximabNicholas A Kennedy, James R Goodhand, Claire Bewshea, et al.
Journal of Crohn'S & Colitis|May 24, 2019
Long-term Outcomes of Paediatric Patients Admitted With Acute Severe Colitis- A Multicentre Study From the Paediatric IBD Porto Group of ESPGHANAlex Krauthammer, Christos Tzivinikos, Amit Assa, et al.
European Journal of Pediatrics|May 3, 2024
STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHANGemma Pujol-Muncunill, Víctor Manuel Navas-López, Oren Ledder, et al.
Nature Communications|June 22, 2022
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel diseaseEva Gonçalves Serra, Tobias Schwerd, Loukas Moutsianas, et al.
Nature Communications|February 22, 2020
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel diseaseEva Gonçalves Serra, Tobias Schwerd, Loukas Moutsianas, et al.
Pageof 23

Showing results (221-230 of 225) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 225 results.
Gut|March 23, 2021
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximabNicholas A Kennedy, James R Goodhand, Claire Bewshea, et al.
Journal of Crohn'S & Colitis|May 24, 2019
Long-term Outcomes of Paediatric Patients Admitted With Acute Severe Colitis- A Multicentre Study From the Paediatric IBD Porto Group of ESPGHANAlex Krauthammer, Christos Tzivinikos, Amit Assa, et al.
European Journal of Pediatrics|May 3, 2024
STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHANGemma Pujol-Muncunill, Víctor Manuel Navas-López, Oren Ledder, et al.
Nature Communications|June 22, 2022
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel diseaseEva Gonçalves Serra, Tobias Schwerd, Loukas Moutsianas, et al.
Nature Communications|February 22, 2020
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel diseaseEva Gonçalves Serra, Tobias Schwerd, Loukas Moutsianas, et al.
Pageof 23